Standardized reporting of extrahepatic cholangiocarcinoma
Maria El Homsi(Memorial Sloan Kettering Cancer Center), Robert M. Marks(University of California San Diego), Ciara O’Brien(University Health Network), Guilherme Moura Cunha(University of Washington), Aliya Qayyum(The University of Texas MD Anderson Cancer Center), David Becker-Weidman(Moffitt Cancer Center), James Costello(Moffitt Cancer Center), Sudhakar K. Venkatesh(Mayo Clinic), Hina Arif‐Tiwari(Banner - University Medical Center Tucson), Frank H. Miller(Northwestern University), Apurva Bonde(The University of Texas at San Antonio Health Science Center), Ryan L. Brunsing(Stanford University), Omar Hassan(University of California, San Francisco), Daniel R. Karolyi(Carilion Clinic)
Cited by 0
Related Papers
Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes
|Gastroenterology|2009|1.1k
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
|Gastroenterology|2016|686
Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
|Gastroenterology|2010|649
A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization
|American Journal of Transplantation|2009|581